Profesionales
Distribución
Si estás interesado en distribuir cualquiera de nuestros productos, o necesitas más información al respecto, puedes contactarnos en:
AnimónComplex
Antianémico. Prometabólico (disminuye la fatiga y el cansancio). Neuroprotector. Refuerza la función psicológica, en casos de depresión, ansiedad, estrés o apatía.
- Peters R, Burch L, Warner J, Beckett N, Poulter R, Bulpitt C. 2008. Haemoglobin, anaemia, dementia and cognitive decline in the elderly, a systematic review. BMC Geriatr, 8, 8:18.
https://bmcgeriatr.biomedcentral.com/articles/10.1186/1471-2318-8-18 - Abugoch James LE. 2009. Quinoa (Chenopodium quinoa Willd.): composition, chemistry, nutritional, and functional properties. Adv Food Nutr Res, 58:1-31.
https://www.sciencedirect.com/science/article/pii/S1043452609580011?via%3Dihub - Shipton MJ, Thachil J. 2015. Vitamin B12 deficiency – A 21st century perspective. Clin Med, 15(2):145-50.
https://www.rcpjournals.org/content/clinmedicine/15/2/145 - Bailey LB, Stover PJ, McNulty H, Fenech MF, Gregory JF 3rd, Mills JL, et al. 2015. Biomarkers of Nutrition for Development-Folate Review. J Nutr, 145(7):1636S-80S.
https://academic.oup.com/jn/article/145/7/1636S/4589945
AntiGan
Indicado para mejorar la tolerancia a los tratamientos oncológicos convencionales.
- Lombardi VRM, Pereira J, Etcheverría I, Fernández-Novoa L, Seoane S and Cacabelos R. 2006. Improvement of immune function by means of Conger conger extract in an in vivo rat model of cold stress. Food and Agricultural Immunology, 17(1-4): 115-127.
https://www.tandfonline.com/doi/full/10.1080/09540100600916569 - Cacabelos R. 2016. Novel Biotechnological Products from Natural Sources: Nutri/Pharmacogenomic Component. J Nutr Food Sci, 6:6.
https://www.longdom.org/open-access/novel-biotechnological-products-from-natural-sources-nutri-pharmacogenomic-component-2155-9600-1000e135.pdf - Cacabelos R. 2017. ProteoLipins and LipoFishins: Novel nutraceuticals and their effects. Open Access Government. Health & Social Care News, January 20.
https://www.openaccessgovernment.org/proteolipins-lipofishins-novel-nutraceuticals-effects/31137/ - Lombardi VRM, Carrera I, Cacabelos R. 2018. In vitro and in vivo cytotoxic effect of AntiGan against tumor cells. Exp Ther Med, 15(3):2547-2556.
https://www.spandidos-publications.com/10.3892/etm.2017.5681 - Cacabelos R, Lombardi VRM, Fernández-Novoa l, Carrera I, Cacabelos P, Corzo L, Carril JC, Teijido O. 2018. Chapter 6 – Basic and Clinical Studies with Marine LipoFishins and Vegetal Favalins in Neurodegeneration and Age-Related Disorders. Volume 59, Pages 195-225.
https://www.sciencedirect.com/science/article/pii/B9780444641793000062 - Lombardi VRM, Carrera I, Corzo L, Cacabelos R. 2019. Role of bioactive lipofishins in prevention of inflammation and colon cancer. Seminars in Cancer Biology, Vol 56, Pages 175-184.
https://www.sciencedirect.com/science/article/abs/pii/S1044579X17302559 - Corzo L, Fernández-Novoa L, Carrera I, Martínez O, Rodríguez S, Alejo R and Cacabelos R. Nutrition, Health, and Disease: Role of Selected Marine and Vegetal Nutraceuticals. Nutrients 2020, 12(3):747.
https://www.mdpi.com/2072-6643/12/3/747 - Martínez-Iglesias O, Carrera I, Naidoo V, Cacabelos R. 2022. AntiGan: An Epinutraceutical Bioproduct with Antitumor Properties in Cultured Cell Lines. Life, 12 (1), 97.
https://doi.org/10.3390/life12010097 - Watanabe Y, Naganuma T, Ogawa T, Muramoto K. 2013. Lectins of Marine Origin and Their Clinical Applications. In: Fang E., Ng T. (eds) Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds. Springer, Dordrecht.
https://doi.org/10.1007/978-94-007-6214-5_4 - Nakamura O, Watanabe T, Kamiya H, Muramoto K. 2001. Galectin containing cells in the skin and mucosal tissues in Japanese conger eel, Conger myriaster: an immunohistochemical study. Developmental and Comparative Immunology. 25(5-6):431-437.
https://doi.org/10.1016/S0145-305X(01)00012-X - Kwak CH, Lee SH, Lee SK, Ha SH, Suh SJ, Kwon KM, et al. 2015. Induction of Apoptosis and Antitumor Activity of Eel Skin Mucus, Containing Lactose-Binding Molecules, on Human Leukemic K562 Cells. Mar. Drugs, 13, 3936-3949.
https://doi.org/10.3390/md13063936
AtreMorine
Fuente natural de L-Dopa. Tratamiento y/o prevención de enfermedades neurodegenerativas, enfermedad de Parkinson y otros síndromes parkinsonianos. Antioxidante.
- Cacabelos R, Fernández-Novoa L, Alejo R, Corzo L, Alcaraz M, Nebril L, et al. 2016. E-PodoFavalin-15999 (Atremorine®)-Induced Dopamine Response in Parkinson’s disease: Pharmacogenetics-Related Effects. Gen Med Pharm, 1(1):1‐26.
- Cacabelos R, Fernández-Novoa L, Alejo R, Corzo L, Alcaraz M, Nebril L, et al. 2016. E-PodoFavalin-15999 (Atremorine®) -Induced Neurotransmitter and Hormonal Response in Parkinson’s Disease. J Exp Res Pharm, 1(1):1-12.
http://www.xiahepublishing.com/ArticleFullText.aspx?sid=2&jid=3&id=10.14218%2FJERP.2016.00031
- Cacabelos R. 2016. Novel Biotechnological Products from Natural Sources: Nutri/Pharmacogenomic Component. J Nutr Food Sci, 6:6.
- Cacabelos R, Carril JC, Teijido O. 2017. Chapter 5. Pharmacogenomics and Epigenomics of Age-Related Neurodegenerative Disorders: Strategies for Drug Development. Anti-aging Drugs: From Basic Research to Clinical Practice, 75-141.
https://pubs.rsc.org/en/content/chapter/bk9781782624356-00075/978-1-78262-435-6
Romero A, Parada E, González‐Lafuente L, Farré‐Alins V, Ramos E, Cacabelos R, Egea J. 2017. Neuroprotective effects of E‐PodoFavalin‐15999 (Atremorine®). CNS Neurosci Ther, 23:450‐452.
Cacabelos R. 2017. Parkinson’s Disease: From Pathogenesis to Pharmacogenomics. Int. J. Mol. Sci. 18(3), 551.
https://www.mdpi.com/1422-0067/18/3/551- Carrera I, Fernandez-Novoa L, Sampedro C, Cacabelos R. 2017. Neuroprotective Effect of AtreMorine in an Experimental Model of Parkinson’s disease. Current Pharmaceutical Design, Vol 23 (18): 2673-2684(12).
https://www.ingentaconnect.com/contentone/ben/cpd/2017/00000023/00000018/art00011#expand/collapse - Cacabelos R, Carril JC, Cacabelos P, Fernández-Novoa L, Arun M. 2017. Pharmacogenetics of Neurodegenerative disorders. Internal Medicine Review, 3. 10.18103/imr.v3i6.472.
https://internalmedicinereview.org/index.php/imr/article/view/472 - Cacabelos R, Lombardi VRM, Fernández-Novoa l, Carrera I, Cacabelos P, Corzo L, et al. 2018. Chapter 6 – Basic and Clinical Studies with Marine LipoFishins and Vegetal Favalins in Neurodegeneration and Age-Related Disorders. Volume 59, Pages 195-225.
https://www.sciencedirect.com/science/article/pii/B9780444641793000062 - Teijido O., Cacabelos R. 2018. Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer’s and Parkinson’s Diseases. Int. J. Mol. Sci. 19, 3199.
- Cacabelos R, Carrera I, Alejo R, Fernández-Novoa L, Cacabelos P, Corzo L, et al. 2019. Pharmacogenetics of Atremorine-Induced Neuroprotection and Dopamine Response in Parkinson’s Disease. Planta Med, 85(17):1351-1362.
https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-1013-7686 - Carrera I, Cacabelos R. 2019. Current Drugs and Potential Future Neuroprotective Compounds for Parkinson’s Disease. Current Neuropharmacol, Volume 17, 3, pp. 295-306(12).
https://doi.org/10.2174/1570159X17666181127125704 - Carrera I, Martinez O, Cacabelos R. 2019. Neuroprotection with Natural Antioxidants and Nutraceuticals in the Context of Brain Cell Degeneration: The Epigenetic Connection. Curr Top Med Chem, 19(32):2999-3011.
10.2174/1568026619666191202155738 - Cacabelos R. 2020. Pharmacogenomics of Alzheimer’s and Parkinson’s diseases. Neurosci Lett, 726: 133807.
https://doi.org/10.1016/j.neulet.2018.09.018 - Corzo L, Fernández-Novoa L, Carrera I, Martínez O, Rodríguez S, Alejo R and Cacabelos R. 2020. Nutrition, Health, and Disease: Role of Selected Marine and Vegetal Nutraceuticals. Nutrients, 12(3):747.
https://www.mdpi.com/2072-6643/12/3/747 - Martínez-Iglesias O, Naidoo V, Carril JC, Carrera I, Corzo L, Rodríguez S, et al. 2020. AtreMorine Treatment Regulates DNA Methylation in Neurodegenerative Disorders: Epigenetic and Pharmacogenetic Studies. Current Pharmacogenomics and Personalized Medicine, 17, 159-171.
http://dx.doi.org/10.2174/1875692117999201231152800 - Cacabelos R, Carrera I, Martínez O, Naidoo V, Cacabelos N, Aliev G, Carril JC. 2021. Influence of dopamine, noradrenaline, and serotonin transporters on the pharmacogenetics of Atremorine in Parkinson’s disease. Drug Dev Res, 1–12.
https://doi.org/10.1002/ddr.21784 - Cacabelos R, Carrera I, Martínez O, Alejo R, Fernandez-Novoa L, Cacabelos P, et al. 2021. Atremorine in Parkinson’s disease: From dopaminergic neuroprotection to pharmacogenomics. Med Res Rev, 1–46.
https://doi.org/10.1002/med.21838
- Cacabelos R, Fernández-Novoa L, Alejo R, Corzo L, Alcaraz M, Nebril L, et al. 2016. E-PodoFavalin-15999 (Atremorine®)-Induced Dopamine Response in Parkinson’s disease: Pharmacogenetics-Related Effects. Gen Med Pharm, 1(1):1‐26.
https://www.scitcentral.com/article/20/75/E-PodoFavalin-15999-(Atremorine%C2%AE)-Induced-Dopamine-Response-in-Parkinson%E2%80%99s-Disease:-Pharmacogenetics-Related-Effects - Cacabelos R, Fernández-Novoa L, Alejo R, Corzo L, Alcaraz M, Nebril L, et al. 2016. E-PodoFavalin-15999 (Atremorine®) -Induced Neurotransmitter and Hormonal Response in Parkinson’s Disease. J Exp Res Pharm, 1(1):1-12.
http://www.xiahepublishing.com/ArticleFullText.aspx?sid=2&jid=3&id=10.14218%2FJERP.2016.00031 - Cacabelos R. 2016. Novel Biotechnological Products from Natural Sources: Nutri/Pharmacogenomic Component. J Nutr Food Sci, 6:6.
https://www.longdom.org/open-access/novel-biotechnological-products-from-natural-sources-nutri-pharmacogenomic-component-2155-9600-1000e135.pdf - Cacabelos R, Carril JC, Teijido O. 2017. Chapter 5. Pharmacogenomics and Epigenomics of Age-Related Neurodegenerative Disorders: Strategies for Drug Development. Anti-aging Drugs: From Basic Research to Clinical Practice, 75-141.
https://pubs.rsc.org/en/content/chapter/bk9781782624356-00075/978-1-78262-435-6 - Romero A, Parada E, González‐Lafuente L, Farré‐Alins V, Ramos E, Cacabelos R, Egea J. 2017. Neuroprotective effects of E‐PodoFavalin‐15999 (Atremorine®). CNS Neurosci Ther, 23:450‐452.
https://onlinelibrary.wiley.com/doi/full/10.1111/cns.12693 - Cacabelos R. 2017. Parkinson’s Disease: From Pathogenesis to Pharmacogenomics. Int. J. Mol. Sci. 18(3), 551.
https://www.mdpi.com/1422-0067/18/3/551 - Carrera I, Fernandez-Novoa L, Sampedro C, Cacabelos R. 2017. Neuroprotective Effect of AtreMorine in an Experimental Model of Parkinson’s disease. Current Pharmaceutical Design, Vol 23 (18): 2673-2684(12).
https://www.ingentaconnect.com/contentone/ben/cpd/2017/00000023/00000018/art00011#expand/collapse - Cacabelos R, Carril JC, Cacabelos P, Fernández-Novoa L, Arun M. 2017. Pharmacogenetics of Neurodegenerative disorders. Internal Medicine Review, 3. 10.18103/imr.v3i6.472.
https://internalmedicinereview.org/index.php/imr/article/view/472 - Cacabelos R, Lombardi VRM, Fernández-Novoa l, Carrera I, Cacabelos P, Corzo L, et al. 2018. Chapter 6 – Basic and Clinical Studies with Marine LipoFishins and Vegetal Favalins in Neurodegeneration and Age-Related Disorders. Volume 59, Pages 195-225.
https://www.sciencedirect.com/science/article/pii/B9780444641793000062 - Teijido O., Cacabelos R. 2018. Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer’s and Parkinson’s Diseases. Int. J. Mol. Sci. 19, 3199.
https://www.mdpi.com/1422-0067/19/10/3199 - Cacabelos R, Carrera I, Alejo R, Fernández-Novoa L, Cacabelos P, Corzo L, et al. 2019. Pharmacogenetics of Atremorine-Induced Neuroprotection and Dopamine Response in Parkinson’s Disease. Planta Med, 85(17):1351-1362.
https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-1013-7686 - Carrera I, Cacabelos R. 2019. Current Drugs and Potential Future Neuroprotective Compounds for Parkinson’s Disease. Current Neuropharmacol, Volume 17, 3, pp. 295-306(12).
https://doi.org/10.2174/1570159X17666181127125704 - Carrera I, Martinez O, Cacabelos R. 2019. Neuroprotection with Natural Antioxidants and Nutraceuticals in the Context of Brain Cell Degeneration: The Epigenetic Connection. Curr Top Med Chem, 19(32):2999-3011.
10.2174/1568026619666191202155738 - Cacabelos R. 2020. Pharmacogenomics of Alzheimer’s and Parkinson’s diseases. Neurosci Lett, 726: 133807.
https://doi.org/10.1016/j.neulet.2018.09.018 - Corzo L, Fernández-Novoa L, Carrera I, Martínez O, Rodríguez S, Alejo R and Cacabelos R. 2020. Nutrition, Health, and Disease: Role of Selected Marine and Vegetal Nutraceuticals. Nutrients, 12(3):747.
https://www.mdpi.com/2072-6643/12/3/747 - Martínez-Iglesias O, Naidoo V, Carril JC, Carrera I, Corzo L, Rodríguez S, et al. 2020. AtreMorine Treatment Regulates DNA Methylation in Neurodegenerative Disorders: Epigenetic and Pharmacogenetic Studies. Current Pharmacogenomics and Personalized Medicine, 17, 159-171.
http://dx.doi.org/10.2174/1875692117999201231152800 - Cacabelos R, Carrera I, Martínez O, Naidoo V, Cacabelos N, Aliev G, Carril JC. 2021. Influence of dopamine, noradrenaline, and serotonin transporters on the pharmacogenetics of Atremorine in Parkinson’s disease. Drug Dev Res, 1–12.
https://doi.org/10.1002/ddr.21784 - Cacabelos R, Carrera I, Martínez O, Alejo R, Fernandez-Novoa L, Cacabelos P, et al. 2021. Atremorine in Parkinson’s disease: From dopaminergic neuroprotection to pharmacogenomics. Med Res Rev, 1–46.
https://doi.org/10.1002/med.21838
CabyMar
Deporte y ejercicio. Mantenimiento y recuperación de la masa muscular, favorece el metabolismo energético y aumenta la eficiencia energética.
- Lombardi VRM, Fernandez-Novoa L, Etcheverria I, Seoane S, Cacabelos R. 2005. Studies on immunological, biochemical, hematological and growth regulation by Scomber scombrus fish protein extract supplementation in young pigs. Animal Science Journal, 76: 159-170.
https://onlinelibrary.wiley.com/doi/10.1111/j.1740-0929.2005.00252.x - Cacabelos R. 2005. Role of Nutrition in the Prevention of Alzheimer´s Disease. Aging Health, 1(3): 359-362.
https://www.futuremedicine.com/doi/abs/10.2217/1745509X.1.3.359 - Lombardi VRM, Fernandez-Novoa L, Etcheverria I, Seoane S, Cacabelos R. 2005. Effects of fish-derived lipoprotein extracts on activation markers, Fas expression and apoptosis in peripheral blood lymphocytes. International Immunopharmacology, 5: 253-262.
https://www.sciencedirect.com/science/article/pii/S1567576904003157?via%3Dihub - Cacabelos R. 2016. Novel Biotechnological Products from Natural Sources: Nutri/Pharmacogenomic Component. J Nutr Food Sci, 6:6.
https://www.longdom.org/open-access/novel-biotechnological-products-from-natural-sources-nutri-pharmacogenomic-component-2155-9600-1000e135.pdf - Cacabelos R. 2017. ProteoLipins and LipoFishins: Novel nutraceuticals and their effects. Open Access Government. Health & Social Care News, January 20.
- Cacabelos R, Lombardi VRM, Fernández-Novoa l, Carrera I, Cacabelos P, Corzo L, Carril JC, Teijido O. 2018. Chapter 6 – Basic and Clinical Studies with Marine LipoFishins and Vegetal Favalins in Neurodegeneration and Age-Related Disorders. Volume 59, Pages 195-225.
https://www.sciencedirect.com/science/article/pii/B9780444641793000062 - Corzo L, Fernández-Novoa L, Carrera I, Martínez O, Rodríguez S, Alejo R, Cacabelos R. 2020. Nutrition, Health, and Disease: Role of Selected Marine and Vegetal Nutraceuticals. Nutrients 2020, 12(3):747.
https://www.mdpi.com/2072-6643/12/3/747
DefenVid
Refuerza el sistema inmunitario en las épocas de catarros y resfriados (primavera y otoño). Antiinflamatorio. Antialérgico.
- Lombardi VRM, Fernandez-Novoa L, Corzo D, Zas R, Cacabelos R. 2002. Enhancement in Immune Function and Growth Using E-JUR-94013®. Methods Find Exp Pharmacol, 24 (9): 573:578.
https://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summary_pr?p_JournalId=6&p_RefId=802309&p_IsPs=N - Lombardi VRM, Fernandez-Novoa L, Etcheverria I, Seoane S, Cacabelos R. 2005. Effects of fish-derived lipoprotein extracts on activation markers, Fas expression and apoptosis in peripheral blood lymphocytes. International Immunopharmacology, 5: 253-262.
https://www.sciencedirect.com/science/article/pii/S1567576904003157?via%3Dihub - Cacabelos R. 2005. Role of Nutrition in the Prevention of Alzheimer´s Disease. Aging Health, 1(3): 359-362.
https://www.futuremedicine.com/doi/abs/10.2217/1745509X.1.3.359 - Cacabelos R. 2016. Novel Biotechnological Products from Natural Sources: Nutri/Pharmacogenomic Component. J Nutr Food Sci, 6:6.
https://www.longdom.org/open-access/novel-biotechnological-products-from-natural-sources-nutri-pharmacogenomic-component-2155-9600-1000e135.pdf - Cacabelos R. 2017. ProteoLipins and LipoFishins: Novel nutraceuticals and their effects. Open Access Government. Health & Social Care News, January 20.
- Cacabelos R, Carril JC, Teijido O. 2017. Chapter 5. Pharmacogenomics and Epigenomics of Age-Related Neurodegenerative Disorders: Strategies for Drug Development. Anti-aging Drugs: From Basic Research to Clinical Practice, 75-141.
https://pubs.rsc.org/en/content/chapter/bk9781782624356-00075/978-1-78262-435-6 - Lombardi VRM, Corzo L, Carrera I and Cacabelos R. 2018. The search for biomarine derived compounds with immunomodulatory activity. J Explor Res Pharmacol, 3(1):30.
http://www.xiahepublishing.com/2572-5505/ArticleFullText.aspx?sid=2&id=10.14218%2FJERP.2018.00006 - Cacabelos R, Lombardi VRM, Fernández-Novoa l, Carrera I, Cacabelos P, Corzo L, Carril JC, Teijido O. 2018. Chapter 6 – Basic and Clinical Studies with Marine LipoFishins and Vegetal Favalins in Neurodegeneration and Age-Related Disorders. Volume 59, Pages 195-225.
https://www.sciencedirect.com/science/article/pii/B9780444641793000062 - Corzo L, Fernández-Novoa L, Carrera I, Martínez O, Rodríguez S, Alejo R and Cacabelos R. 2020. Nutrition, Health, and Disease: Role of Selected Marine and Vegetal Nutraceuticals. Nutrients, 12(3):747.
https://www.mdpi.com/2072-6643/12/3/747
HepatoSar
Hepatoprotector. Favorece la función digestiva e intestinal. Previene la formación de cálculos biliares.
- Lombardi VRM and Cacabelos R. 1999. E-SAR-94010®: a marine fish extract obtained by advanced biotechnological methods. Drugs of the Future, 24(2): 167-176.
https://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summary_pr?p_JournalId=2&p_RefId=527660&p_IsPs=N - Lombardi VRM, Cagiao A, Fernández-Novoa L, Álvarez XA, Corzo MD, Zas R, Sampedro C and Cacabelos R. 2001. Short term food supplementation effects of a fish derived extract on the immunological status of pregnant rats and their sucking pups. Nutrition Research, 21: 1425-1434.
https://www.sciencedirect.com/science/article/pii/S027153170100361X - Cacabelos R, Vallejo AI, Lombardi VRM, Fernández-Novoa L and Pichel V. 2004. E-SAR-94010®: a pleiotropic lipoprotein compound with powerful anti-atheromatous and lipid lowering effects. CNS Drug Reviews, vol. 10 (2).
https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1527-3458.2004.tb00021.x - Cacabelos R. 2005. Role of Nutrition in the Prevention of Alzheimer´s Disease. Aging Health, 1(3): 359-362.
https://www.futuremedicine.com/doi/abs/10.2217/1745509X.1.3.359 - Cacabelos R. 2005. Pharmacogenomics, nutrigenomics, and therapeutic optimization in Alzheimer’s disease. Future Medicine. Aging Health, 1(2):303-348.
https://www.futuremedicine.com/doi/10.2217/1745509X.1.2.303 - Cacabelos R. 2008. Application of nutrigenomics to Alzheimer’s disease. Agro Food Industry Hi-Tech. 19.
- Cacabelos, R. 2008. Pharmacogenomics in Alzheimer’s disease. Meth Mol Biol, 448:213-357.
10.1007/978-1-59745-205-2_10 - Cacabelos R, Fernández-Novoa L, Martínez-Bouza R, McKay A, Carril JC, Lombardi V, et al. 2010. Future trends in the pharmacogenomics of brain disorders and dementia: Influence of APOE and CYP2D6 variants. Pharmaceuticals 3:3040-3100.
https://doi.org/10.3390/ph3103040 - Cacabelos R. 2016. Novel Biotechnological Products from Natural Sources: Nutri/Pharmacogenomic Component. J Nutr Food Sci, 6:6.
https://www.longdom.org/open-access/novel-biotechnological-products-from-natural-sources-nutri-pharmacogenomic-component-2155-9600-1000e135.pdf - Cacabelos R, Carril JC, Cacabelos P, Teijido O, Goldgaber D. 2016. Pharmacogenomics of Alzheimer’s Disease: Genetic Determinants of Phenotypic Variation and Therapeutic Outcome. J Genomic Med Pharmacogenomics, 1(2): 151-209.
- Cacabelos R. 2017. ProteoLipins and LipoFishins: Novel nutraceuticals and their effects. Open Access Government. Health & Social Care News, January 20.
- Cacabelos R, Carril JC, Teijido O. 2017. Chapter 5. Pharmacogenomics and Epigenomics of Age-Related Neurodegenerative Disorders: Strategies for Drug Development. Anti-aging Drugs: From Basic Research to Clinical Practice, 75-141.
https://pubs.rsc.org/en/content/chapter/bk9781782624356-00075/978-1-78262-435-6 - Cacabelos R, Meyyazhagan A, Carril JC, Cacabelos R, Teijido O. 2018. Pharmacogenetics of vascular risk factors in Alzheimer’s Disease. J Pers Med, 8(3).
https://doi.org/10.3390/jpm8010003 - Cacabelos R, Lombardi VRM, Fernández-Novoa l, Carrera I, Cacabelos P, Corzo L, Carril JC, Teijido O. 2018. Chapter 6 – Basic and Clinical Studies with Marine LipoFishins and Vegetal Favalins in Neurodegeneration and Age-Related Disorders. Volume 59, Pages 195-225.
https://www.sciencedirect.com/science/article/pii/B9780444641793000062 - Corzo L, Fernández-Novoa L, Carrera I, Martínez O, Rodríguez S, Alejo R and Cacabelos R. 2020. Nutrition, Health, and Disease: Role of Selected Marine and Vegetal Nutraceuticals. Nutrients, 12(3):747.
https://www.mdpi.com/2072-6643/12/3/747 - Salem MB, Affes H, Ksouda K, Dhouibi R, Sahnoun Z, Hammami S, Zeghal KM. 2015. Pharmacological Studies of Artichoke Leaf Extract and Their Health Benefits. Plant Foods Hum Nutr, 70(4):441-53.
https://link.springer.com/article/10.1007/s11130-015-0503-8 - Salekzamani S, Ebrahimi‐Mameghani M, and Rezazadeh K. 2019. The antioxidant activity of artichoke (Cynara scolymus): A systematic review and meta‐analysis of animal studies. Phytother Res, 33(1):55-71.
https://onlinelibrary.wiley.com/doi/abs/10.1002/ptr.6213
LipoEsar
Hipolipemiante y antiaterosclerótico. Disminuye el colesterol y los triglicéridos. Mejora la salud cardiovascular.
- Lombardi VRM and Cacabelos R. 1999. E-SAR-94010®: a marine fish extract obtained by advanced biotechnological methods. Drugs of the Future, 24(2): 167-176.
https://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summary_pr?p_JournalId=2&p_RefId=527660&p_IsPs=N - Lombardi VRM, Cagiao A, Fernández-Novoa L, Álvarez XA, Corzo MD, Zas R, Sampedro C and Cacabelos R. 2001. Short term food supplementation effects of a fish derived extract on the immunological status of pregnant rats and their sucking pups. Nutrition Research, 21: 1425-1434.
https://www.sciencedirect.com/science/article/pii/S027153170100361X - Cacabelos R, Vallejo AI, Lombardi VRM, Fernández-Novoa L and Pichel V. 2004. E-SAR-94010®: a pleiotropic lipoprotein compound with powerful anti-atheromatous and lipid lowering effects. CNS Drug Reviews, vol. 10 (2).
https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1527-3458.2004.tb00021.x - Cacabelos R. 2005. Role of Nutrition in the Prevention of Alzheimer´s Disease. Aging Health, 1(3): 359-362.
https://www.futuremedicine.com/doi/abs/10.2217/1745509X.1.3.359 - Cacabelos R. 2005. Pharmacogenomics, nutrigenomics, and therapeutic optimization in Alzheimer’s disease. Future Medicine. Aging Health, 1(2):303-348.
https://www.futuremedicine.com/doi/10.2217/1745509X.1.2.303 - Cacabelos R. 2008. Application of nutrigenomics to Alzheimer’s disease. Agro Food Industry Hi-Tech. 19.
- Cacabelos, R. 2008. Pharmacogenomics in Alzheimer’s disease. Meth Mol Biol, 448:213-357.
10.1007/978-1-59745-205-2_10 - Cacabelos R, Fernández-Novoa L, Martínez-Bouza R, McKay A, Carril JC, Lombardi V, et al. 2010. Future trends in the pharmacogenomics of brain disorders and dementia: Influence of APOE and CYP2D6 variants. Pharmaceuticals 3:3040-3100.
https://doi.org/10.3390/ph3103040 - Cacabelos R. 2016. Novel Biotechnological Products from Natural Sources: Nutri/Pharmacogenomic Component. J Nutr Food Sci, 6:6.
https://www.longdom.org/open-access/novel-biotechnological-products-from-natural-sources-nutri-pharmacogenomic-component-2155-9600-1000e135.pdf - Cacabelos R, Carril JC, Cacabelos P, Teijido O, Goldgaber D. 2016. Pharmacogenomics of Alzheimer’s Disease: Genetic Determinants of Phenotypic Variation and Therapeutic Outcome. J Genomic Med Pharmacogenomics, 1(2): 151-209.
- Cacabelos R. 2017. ProteoLipins and LipoFishins: Novel nutraceuticals and their effects. Open Access Government. Health & Social Care News, January 20.
- Cacabelos R, Carril JC, Teijido O. 2017. Chapter 5. Pharmacogenomics and Epigenomics of Age-Related Neurodegenerative Disorders: Strategies for Drug Development. Anti-aging Drugs: From Basic Research to Clinical Practice, 75-141.
https://pubs.rsc.org/en/content/chapter/bk9781782624356-00075/978-1-78262-435-6 - Cacabelos R, Meyyazhagan A, Carril JC, Cacabelos R, Teijido O. 2018. Pharmacogenetics of vascular risk factors in Alzheimer’s Disease. J Pers Med 2018; 8(3).
https://doi.org/10.3390/jpm8010003 - Cacabelos R, Lombardi VRM, Fernández-Novoa l, Carrera I, Cacabelos P, Corzo L, Carril JC, Teijido O. 2018. Chapter 6 – Basic and Clinical Studies with Marine LipoFishins and Vegetal Favalins in Neurodegeneration and Age-Related Disorders. Volume 59, Pages 195-225.
https://www.sciencedirect.com/science/article/pii/B9780444641793000062 - Corzo L, Fernández-Novoa L, Carrera I, Martínez O, Rodríguez S, Alejo R and Cacabelos R. 2020. Nutrition, Health, and Disease: Role of Selected Marine and Vegetal Nutraceuticals. Nutrients, 12(3):747.
https://www.mdpi.com/2072-6643/12/3/747
MakaliSex
Mejora la salud sexual en hombres y en mujeres. Indicado para problemas de infertilidad en el hombre. Energizante.
- Gonzales GF. 2012. Ethnobiology and Ethnopharmacology of Lepidium meyenii (Maca), a Plant from the Peruvian Highlands. Evid Based Complement Alternat Med, 2012:193496.
https://www.hindawi.com/journals/ecam/2012/193496/ - Zenico T, Cicero AF, Valmorri L, Mercuriali M, Bercovich E. 2009. Subjective effects of Lepidium meyenii (Maca) extract on well-being and sexual performances in patients with mild erectile dysfunction: a randomised, double-blind clinical trial. Andrologia, 41(2):95-9.
https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1439-0272.2008.00892.x - Lee MS, Shin BC, Yang EJ, Lim HJ, Ernst E. 2011. Maca (Lepidium meyenii) for treatment of menopausal symptoms: A systematic review. Maturitas, 70(3):227-33.
https://www.maturitas.org/article/S0378-5122(11)00262-3/fulltext - Qazi IH, Angel C, Yang H, Zoidis E, Pan B, Wu Z, Ming Z, Zeng CJ, Meng Q, Han H, Zhou G. 2019. Role of Selenium and Selenoproteins in Male Reproductive Function: A Review of Past and Present Evidence. Antioxidants (Basel), 2;8(8):268.
https://www.mdpi.com/2076-3921/8/8/268 - Prasad AS, Mantzoros CS, Beck FW, Hess JW, Brewer GJ. 1996. Zinc status and serum testosterone levels of healthy adults. Nutrition, 12(5):344-348.
https://www.sciencedirect.com/science/article/abs/pii/S089990079680058X?via%3Dihub
MineraXin
Para la salud ósea y articular. Útil en la prevención de la osteoporosis. Aumenta la vitamina D. Mejora la sintomatología asociada a la menopausia y perimenopausia.
- Corzo L, Rodríguez S, Lombardi V, Alejo R, Cacabelos R. 2013. Propiedades biológicas de MineraXin. Gen-T 9: 31-39.
- Cacabelos R. 2016. Novel Biotechnological Products from Natural Sources: Nutri/Pharmacogenomic Component. J Nutr Food Sci, 6:6.
https://www.longdom.org/open-access/novel-biotechnological-products-from-natural-sources-nutri-pharmacogenomic-component-2155-9600-1000e135.pdf - Cacabelos R. 2017. ProteoLipins and LipoFishins: Novel nutraceuticals and their effects. Open Access Government. Health & Social Care News, January 20.
https://www.openaccessgovernment.org/proteolipins-lipofishins-novel-nutraceuticals-effects/31137/ - Corzo L, Rodriguez S, Alejo R, Fernandez-Novoa L, Aliev G, Cacabelos R. 2017. E-MHK-0103 (Mineraxin™): A Novel Nutraceutical with Biological Properties in Menopausal Conditions. Curr Drug Metab, 18(1):39-49.
https://www.eurekaselect.com/146323/article - Cacabelos R, Lombardi VRM, Fernández-Novoa l, Carrera I, Cacabelos P, Corzo L, Carril JC, Teijido O. 2018. Chapter 6 – Basic and Clinical Studies with Marine LipoFishins and Vegetal Favalins in Neurodegeneration and Age-Related Disorders. Volume 59, Pages 195-225.
https://www.sciencedirect.com/science/article/pii/B9780444641793000062 - Corzo L, Fernández-Novoa L, Carrera I, Martínez O, Rodríguez S, Alejo R and Cacabelos R. 2020. Nutrition, Health, and Disease: Role of Selected Marine and Vegetal Nutraceuticals. Nutrients, 12(3):747.
https://www.mdpi.com/2072-6643/12/3/747 - Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, Bjelakovic M, Gluud C. 2011. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database of Systematic Reviews 2011, Issue 7. Art. No.: CD007470.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007470.pub2/full - Grienke U, Silke J, Tasdemir D. 2014. Bioactive compounds from marine mussels and their effects on human health. Food Chem, 142:48-60.
https://www.sciencedirect.com/science/article/abs/pii/S0308814613009539?via%3Dihub
NeoBrainine
Nutriente cerebral. Trastornos neurológicos. Problemas de memoria. Deterioro cognitivo. Patología cerebrovascular. Demencias.
- Cacabelos R, Álvarez XA, Franco A, Fernández-Novoa L, Caamaño J, Valle-Inclán F. 1992. Therapeutic effects of CDP-choline in Alzheimer’s disease and multi-infarct dementia: psychometric assessment and immune function. Ann Psychiat, 3: 233-245.
- Cacabelos R, Alvarez XA, Franco-Maside A, Fernández-Novoa L, Caamaño J. 1993. Effect of CDP-choline on cognition and immune function in Alzheimer’s disease and multi-infarct dementia. Ann N Y Acad Sci. 24, 695:321-3.
10.1111/j.1749-6632.1993.tb23076.x - Caamaño J, Gómez MJ, Franco A, Cacabelos R. 1994. Effects of CDP-choline on cognition and cerebral hemodynamics in patients with Alzheimer’s disease. Methods Find Exp Clin Pharmacol, 16(3): 211-8.
PMID: 7913981 - Fernández-Novoa L, Alvarez XA, Franco-Maside A, Caamaño J, Cacabelos R. 1994. CDP-choline-induced blood histamine changes in Alzheimer’s disease. Methods Find Exp Clin Pharmacol, 16(4): 279-84.
PMID: 8051988 - Franco-Maside A, Caamaño J, Gómez MJ, Cacabelos R. 1994. Brain mapping activity and mental performance after chronic treatment with CDP-choline in Alzheimer’s disease. Methods Find Exp Clin Pharmacol, 16(8): 597-607. Clinical Trial
PMID: 7760585 - Cacabelos R, Caamaño J, Gómez MJ, Fernández-Novoa L, Franco-Maside A, Vinagre D, Novo B, Zas R, Álvarez XA. 1995. Treatment of Alzheimer’s disease with CDP-choline: Effects on mental performance, brain electrical activity, cerebrovascular parameters, and cytokine production. Ann Psychiat, 5: 295-315.
- Alvarez XA, Laredo M, Corzo D, Fernández-Novoa L, Mouzo R, Perea JE, Daniele D, Cacabelos R. 1997. Citicoline improves memory performance in elderly subjects. Methods Find Exp Clin Pharmacol, 19(3): 201-10.
PMID: 9203170 Clinical Trial. - Alvarez XA, Mouzo R, Pichel V, Pérez P, Laredo M, Fernández-Novoa L, Corzo L, Zas R, Alcaraz M, Secades JJ, Lozano R, Cacabelos R. 1999. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer’s disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion. Methods Find Exp Clin Pharmacol, 21(9):633-44. Clinical Trial.
PMID: 10669911 - Álvarez XA, Sampedro C, Cacabelos R. 1999. Antiapoptotic effects of CDP-choline in a combined (Ab4/hypoperfusion) animal model of hippocampal neurodegeneration. Ann Psychiatry, 7:147-156.